Literature DB >> 11156947

Diseases of liporegulation: new perspective on obesity and related disorders.

R H Unger1, L Orci.   

Abstract

Obesity-related diseases now threaten to reach epidemic proportions in the United States. Here we review in a rodent model of genetic obesity, the fa/fa Zucker diabetic fatty (ZDF) rat, the mechanisms involved in the most common complications of diet-induced human obesity, i.e., noninsulin-dependent diabetes mellitus, and myocardial dysfunction. In ZDF rats, hyperphagia leads to hyperinsulinemia, which up-regulates transcription factors that stimulate lipogenesis. This causes ectopic deposition of triacylglycerol in nonadipocytes, providing fatty acid (FA) substrate for damaging pathways of nonoxidative metabolism, such as ceramide synthesis. In beta cells and myocardium, the resulting functional impairment and apoptosis cause diabetes and cardiomyopathy. Interventions that lower ectopic lipid accumulation or block nonoxidative metabolism of FA and ceramide formation completely prevent these complications. Given the evidence for a similar etiology for the complications of human obesity, it would be appropriate to develop strategies to avert the predicted epidemic of lipotoxic disorders.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11156947     DOI: 10.1096/fj.00-0590

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  84 in total

Review 1.  Regulation of lipid stores and metabolism by lipophagy.

Authors:  K Liu; M J Czaja
Journal:  Cell Death Differ       Date:  2012-05-18       Impact factor: 15.828

2.  Hyperglycemia in rodent models of type 2 diabetes requires insulin-resistant alpha cells.

Authors:  Young Lee; Eric D Berglund; Xinxin Yu; May-Yun Wang; Matthew R Evans; Philipp E Scherer; William L Holland; Maureen J Charron; Michael G Roth; Roger H Unger
Journal:  Proc Natl Acad Sci U S A       Date:  2014-08-25       Impact factor: 11.205

3.  Persisting neural and endocrine modifications induced by a single fat meal.

Authors:  Claude Rouch; Marie-Josée Meile; Kyriaki Gerozissis
Journal:  Cell Mol Neurobiol       Date:  2005-09       Impact factor: 5.046

Review 4.  The metabolic syndrome and the heart--a considered opinion.

Authors:  J G Leichman; V R Lavis; D Aguilar; C R Wilson; H Taegtmeyer
Journal:  Clin Res Cardiol       Date:  2006-01       Impact factor: 5.460

5.  The equivocal metabolic response to endotoxaemia in type 2 diabetic and obese ZDF rats.

Authors:  L Belabed; G Senon; M-C Blanc; A Paillard; L Cynober; S Darquy
Journal:  Diabetologia       Date:  2006-04-19       Impact factor: 10.122

6.  Effects of obesity on the pharmacodynamics of nitroglycerin in conscious rats.

Authors:  Ellen Q Wang; Ho-Leung Fung
Journal:  AAPS PharmSci       Date:  2002

7.  Targeted elimination of peroxisome proliferator-activated receptor gamma in beta cells leads to abnormalities in islet mass without compromising glucose homeostasis.

Authors:  Evan D Rosen; Rohit N Kulkarni; Pasha Sarraf; Umut Ozcan; Terumasa Okada; Chung-Hsin Hsu; Daniel Eisenman; Mark A Magnuson; Frank J Gonzalez; C Ronald Kahn; Bruce M Spiegelman
Journal:  Mol Cell Biol       Date:  2003-10       Impact factor: 4.272

8.  Original Research: Polyphenols extracted from grape powder induce lipogenesis and glucose uptake during differentiation of murine preadipocytes.

Authors:  Sheida Torabi; Nancy M DiMarco
Journal:  Exp Biol Med (Maywood)       Date:  2016-04-25

9.  Controlled downregulation of the cannabinoid CB1 receptor provides a promising approach for the treatment of obesity and obesity-derived type 2 diabetes.

Authors:  Dai Lu; Rachel Dopart; Debra A Kendall
Journal:  Cell Stress Chaperones       Date:  2016-01       Impact factor: 3.667

10.  Inhibition of serine palmitoyltransferase reduces Aβ and tau hyperphosphorylation in a murine model: a safe therapeutic strategy for Alzheimer's disease.

Authors:  Hirosha Geekiyanage; Aditi Upadhye; Christina Chan
Journal:  Neurobiol Aging       Date:  2013-03-23       Impact factor: 4.673

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.